Open AccessStorkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression
Author(s) -
Tomonori Sasahira,
Yukiko Nishiguchi,
Rina Fujiwara,
Miyako Kurihara,
Tadaaki Kirita,
AnjaKatrin Bosserhoff,
Hiroki Kuniyasu
Publication year - 2016
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.8495
Subject(s) - medicine , immunostaining , immunohistochemistry , downregulation and upregulation , cancer research , metastasis , cancer , melanoma , paracrine signalling , pathology , oncology , biology , gene , biochemistry , receptor
Storkhead box protein 2 (STOX2) is a transcriptional factor associated with pre-eclampsia with fetal growth restriction. We recently reported that melanoma inhibitory activity (MIA) promotes oral squamous cell carcinoma (OSCC) progression. However, the relationship between STOX2 and MIA remains unknown in malignancies.